πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9657292

Compositions and methods for treating or preventing lupus

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9655366

Volatile blends and the effects thereof on the navel orangeworm moth

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9657066

Pseudomonas exotoxin A with less immunogenic B cell epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9657096

Human domain antibodies against components of the human insulin-like growth factor (IGF) s

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9651462

Method and system for sampling and separating submicron-sized particles based on density a

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9650422

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9649343

Compositions and methods for transplantation of colon microbiota

National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9650352

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydr

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9649339

LAT adapter molecule for enhanced T-cell signaling and method of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9644179

Use of PDL1 expressing cells to convert T cells into regulatory T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9644216

Adeno-associated virus vectors for treatment of glycogen storage disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9629899

Targeted cargo protein combination therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9631192

Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9629897

Methods of producing and using regulatory B-cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9629816

Small molecule therapeutic compounds targeting thioesterase deficiency disorders and metho

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9624306

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of sa

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9624475

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9623020

Thio compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9623097

Yeast-brachyury immunotherapeutic compositions

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9617229

Phenylmorpholines and analogues thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9617526

Mutated organophosphorus acid anhydrolases and their uses thereof

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9616073

Method for on-demand contraception

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9610338

Serologic correlates of protection against bacillus anthracis infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9605044

Methods and compositions for modulating immune tolerance

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted